KRYS - Financial Reports List - Krystal Biotech, Inc. - IntrinsicAlpha

Krystal Biotech, Inc. KRYS

Healthcare - Biotechnology - NASDAQ - US

$ 164.26

-3.95 %

$ 4.75 B

Market Cap

53.97

P/E

FINANCIAL REPORTS

Reports

Report			Date	Revenue YoY	Net Income YoY	Operating Income YoY	View
Quarterly Report	Q4	8-K	2024-12-31	116.26%	423.23%	1218.64%
Annual Report	FY	10-K	2024-12-31	473.02%	715.58%	159.87%
Quarterly Report	Q3	8-K	2024-09-30	879.91%	-66.34%	186.30%
Quarterly Report	Q2	8-K	2024-06-30	0.00%	146.88%	155.37%
Quarterly Report	Q1	8-K	2024-03-31	0.00%	102.06%	86.31%
Quarterly Report	Q4	8-K	2023-12-31	0.00%	127.12%	109.02%
Annual Report	FY	10-K	2023-12-31	0.00%	107.81%	24.43%
Quarterly Report	Q3	8-K	2023-09-30	0.00%	370.51%	17.35%
Quarterly Report	Q2	8-K	2023-06-30	0.00%	-18.15%	-32.33%
Quarterly Report	Q1	8-K	2023-03-31	0.00%	9.34%	2.79%

1